Effects of Freund's Adjuvant on Ehrlich Ascites Carcinoma in Mice
Author Information
Author(s): F. Hartveit
Primary Institution: University of Bergen, School of Medicine
Hypothesis
How does the combination of Freund's adjuvant with Ehrlich's ascites carcinoma affect tumor cell viability and immune response in mice?
Conclusion
The combination of Freund's adjuvant with Ehrlich's ascites carcinoma does not adversely affect tumor growth and can influence immune responses differently in male and female mice.
Supporting Evidence
- The survival time of mice with combined treatment was similar to those with untreated tumors.
- Female mice showed greater natural immunity compared to males.
- Marked differences in immune response were observed based on the timing of injections.
Takeaway
This study looked at how a special treatment affects cancer in mice. It found that the treatment doesn't hurt the cancer cells and that male and female mice react differently.
Methodology
Mice were injected with combinations of Freund's adjuvant and Ehrlich's ascites carcinoma, and their survival times and tumor responses were measured.
Potential Biases
Potential bias due to the small sample size and the specific strain of mice used.
Limitations
The study did not explore long-term effects beyond the observed survival times.
Participant Demographics
30 male and 30 female mice were used in the experiments.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website